GSK Bribery Scandal

photo

GSK due to report Q2 earnings
GSK CEO may come to China
Drug maker under fire for financial fraud

International pharmaceutical companies Sanofi and Eli Lilly and Company Thursday confirmed that they have been approached by a local industry and commerce administration in China.

GSK investigation reveals something rotten

China's investigation exposed a rotten core in the nation's medical system that needs to be addressed.

AstraZeneca probed in China amid GSK scandal

After bribery allegations were raised against GlaxoSmithKline (GSK), Chinese police have targeted another global leading drug maker AstraZeneca (AZ).

Latest News

·Police closes investigation on GSK China's bribery case
·Police reveals more details about GSK China's suspected violations
·Feeling like 'scapegoat' not to help foreign firms win in Chinese market
·France's Sanofi responds to bribery allegations
·Pharm giant suspected of bribery
·Transparency demanded in doctor-company relations
·Less loopholes for int'l firms in China

Q&A on GSK bribery scandal

Why GSK has been accused?
GSK executives handed out bribes to doctors and took cash rake-offs

·GSK investigated for bribery, tax violations
·Four GSK China execs held for investigation
·GSK execs allegedly received sexual services
·AstraZeneca probed in China amid GSK scandal

What did company say?
The company deeply concerned and disappointed about the allegations

·Emerging markets head apologises for bribery scandal
·GSK to cooperate with China in investigation
·GSK executives in China to handle the scandal
·GSK CEO may come to China

What did Chinese govt say?
China says GSK probe part of business climate clean-up

·China vows to punish harmful practices in medical sector
·Senior Chinese police official meets GSK representative after scandal
·GSK case does not mean change in China's foreign investment policy